These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia. Kantarjian HM; Vellekoop L; McCredie KB; Keating MJ; Hester J; Smith T; Barlogie B; Trujillo J; Freireich EJ J Clin Oncol; 1985 Feb; 3(2):192-200. PubMed ID: 3855444 [TBL] [Abstract][Full Text] [Related]
5. Treatment of the lymphoid blast crisis of chronic myeloid leukemia. Bassan R; Battista R; Comotti B; Minetti B; Chisesi T; Dini E; Barbui T Eur J Cancer Clin Oncol; 1987 May; 23(5):513-5. PubMed ID: 3477457 [TBL] [Abstract][Full Text] [Related]
6. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. Lauten M; Möricke A; Beier R; Zimmermann M; Stanulla M; Meissner B; Odenwald E; Attarbaschi A; Niemeyer C; Niggli F; Riehm H; Schrappe M Haematologica; 2012 Jul; 97(7):1048-56. PubMed ID: 22271901 [TBL] [Abstract][Full Text] [Related]
7. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. Koller CA; Miller DM N Engl J Med; 1986 Dec; 315(23):1433-8. PubMed ID: 2431313 [TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea and 6-mercaptopurine in the treatment of chronic granulocytic leukemia. Lazzarino M; Morra E; Brusamolino E; Inverardi D; Castelli G; Merante S; Bernasconi C Am J Clin Oncol; 1986 Feb; 9(1):45-9. PubMed ID: 3513537 [TBL] [Abstract][Full Text] [Related]
9. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Kantarjian HM; Smith TL; McCredie KB; Keating MJ; Walters RS; Talpaz M; Hester JP; Bligham G; Gehan E; Freireich EJ Blood; 1985 Dec; 66(6):1326-35. PubMed ID: 3864497 [TBL] [Abstract][Full Text] [Related]
10. Therapy of the blast phase of chronic granulocytic leukemia with mithramycin and hydroxyurea. Queisser W; Herrmann F; Lindemann A; Anger B; Hiddemann W; Krey U Onkologie; 1988 Jun; 11(3):145-6. PubMed ID: 2970612 [No Abstract] [Full Text] [Related]
11. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia. Paciucci PA; Keaveney C; Cuttner J; Holland JF Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201 [TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia. Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Smith TL; Talpaz M; Beran M; Cork A; Trujillo JM; Freireich EJ Cancer; 1986 Nov; 58(9):2023-30. PubMed ID: 3463397 [TBL] [Abstract][Full Text] [Related]
13. Prognosis of elderly patients with acute myelogenous leukemia: analysis of 126 AML cases. Iwakiri R; Ohta M; Mikoshiba M; Tsutsumi H; Kumakawa T; Mori M Int J Hematol; 2002 Jan; 75(1):45-50. PubMed ID: 11843290 [TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia. Paciucci PA; Cuttner J; Holland JF Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264 [TBL] [Abstract][Full Text] [Related]
15. Clinical investigation of human alpha interferon in chronic myelogenous leukemia. Talpaz M; Kantarjian HM; McCredie KB; Keating MJ; Trujillo J; Gutterman J Blood; 1987 May; 69(5):1280-8. PubMed ID: 3471281 [TBL] [Abstract][Full Text] [Related]
19. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Inhorn RC; Aster JC; Roach SA; Slapak CA; Soiffer R; Tantravahi R; Stone RM Blood; 1995 Apr; 85(7):1881-7. PubMed ID: 7661940 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of day 14 blast percentage and the absolute blast index in bone marrow of children with acute lymphoblastic leukemia. Visser JH; Wessels G; Hesseling PB; Louw I; Oberholster E; Mansvelt EP Pediatr Hematol Oncol; 2001; 18(3):187-91. PubMed ID: 11293286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]